Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Title:
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Author:
Fisher, Julie G. Tait, David Garrett-Mayer, Elizabeth Halabi, Susan Mangat, Pam K. Schink, Julian C. Alvarez, Ricardo H. Veljovich, Dan Cannon, Timothy L. Crilley, Pamela A. Pollock, Theodore Calfa, Carmen J. Al Baghdadi, Tareq Thota, Ramya Fleming, Nicole Cotta, Jared A. Rygiel, Andrew L. Warren, Sasha L. Schilsky, Richard L.